Wanbury Limited (NSE: WANBURY)

Market Cap	7.74B
Revenue (ttm)	5.77B
Net Income (ttm)	529.62M
Shares Out	n/a
EPS (ttm)	15.65
PE Ratio	14.62
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	39,342
Average Volume	149,065
Open	223.50
Previous Close	228.10
Day's Range	223.20 - 239.50
52-Week Range	123.00 - 323.53
Beta	0.53
RSI	37.54
Earnings Date	Feb 7, 2025

About Wanbury

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for gynecology, orthopedics, hematinic, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive t...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1988
• Employees: 1,491
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: WANBURY